ENOV
Enovis CorpNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.29B
P/E Ratio
—
EPS
$-20.72
Beta
1.59
52W High
$37.85
52W Low
$21.00
50-Day MA
$23.67
200-Day MA
$27.25
Dividend Yield
—
Profit Margin
-52.70%
Forward P/E
6.36
PEG Ratio
1.90
About Enovis Corp
Enovis Corporation is a global medical technology company. The company is headquartered in Wilmington, Delaware.
Fundamentals
| Revenue (TTM) | $2.25B |
| Gross Profit (TTM) | $1.37B |
| EBITDA | $369.17M |
| Operating Margin | 6.09% |
| Return on Equity | -58.30% |
| Return on Assets | 1.09% |
| Revenue/Share (TTM) | $39.39 |
| Book Value | $26.05 |
| Price-to-Book | 0.90 |
| Price-to-Sales (TTM) | 0.58 |
| EV/Revenue | 1.196 |
| EV/EBITDA | 22.42 |
| Quarterly Earnings Growth (YoY) | 153.10% |
| Quarterly Revenue Growth (YoY) | 2.60% |
| Shares Outstanding | $57.54M |
| Float | $56.44M |
| % Insiders | 1.48% |
| % Institutions | 117.42% |
Historical Volatility
HV 10-Day
74.28%
HV 20-Day
59.69%
HV 30-Day
57.80%
HV 60-Day
57.04%
HV Rank
79.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($45.00 target)
2
Strong Buy9
Buy1
HoldData last updated: 4/30/2026